The demise of 23andMe illustrates the vulnerable state of Americans' health data, as med tech companies vacuum up more personal information with little regulatory oversight.
Why it matters: Fitness trackers, wellness apps, genetic tests and other direct-to-consumer tools that capture personal health information aren't subject to federal health data privacy laws. That could open the door to fraud or discrimination.